Trevor M. Polischuck, Ph.D. Public Equity Partner, OrbiMed Advisors LLC, updates on the Worldwide Healthcare Trust PLC.
Tumult in healthcare was the hallmark for mid-March, as a shift in investor sentiment led to an unwinding of support for momentum-driven, high growth sectors in favour of low-beta, value stocks. Despite the volatility, OrbiMed view the setback as somewhat healthy and the shift as temporary, namely some profit taking after a multi-year bull run.
Worldwide Healthcare Trust PLC conducts its affairs so that its shares can be recommended by independent financial advisers ("IFAs") to retail private investors. The shares are excluded from the Financial Conduct Authority's ("FCA's") restrictions which apply to non-mainstream investment products because they are shares in a UK-listed investment trust.
To request emailed copies of monthly fact sheets and other relevant information, please register below.